摘要
目的 研究高迁移率族蛋白B1 (HMGB 1)/Toll样受体4(TLR4)在胶质瘤瘤体及瘤周组织的表达情况,探讨胶质瘤相关性癫痫的发生机制. 方法 收集郑州大学第五附属医院神经外科自2011年6月至2014年6月手术切除的95例胶质瘤标本,其中低级别胶质瘤(WHO Ⅰ~Ⅱ级)55例,高级别胶质瘤(WHOⅢ~Ⅳ)级40例.免疫组化染色、RT-PCR分别检测胶质瘤瘤体、瘤周组织HMGB1及TLR4蛋白和mRNA的表达. 结果 95例胶质瘤患者中,伴癫痫发作34例(35.79%).低级别胶质瘤患者的癫痫发生率(49.09%)高于高级别胶质瘤患者(17.50%),差异有统计学意义(x2=10.057,P=0.002);伴发癫痫胶质瘤瘤周组织中HMGB1、TLR4蛋白表达阳性率和mRNA表达均高于不伴癫痫胶质瘤瘤周组织,差异有统计学意义(P<0.05);伴、不伴癫痫胶质瘤瘤体组织HMGB1、TLR4蛋白和mRNA的表达比较差异均无统计学意义(P>0.05). 结论 瘤周组织中高表达的HMGB1及TLR4可能参与胶质瘤相关性癫痫的发生发展,有可能成为胶质瘤相关性癫痫治疗的新靶点.
Objective To investigate the expression of high mobility group protein b 1 (HMGPB1) and toll-like receptors 4 (TLR4) in human glioma tissues of patients with epilepsy and explore the mechanism of glioma-associated epilepsy.Methods Ninety-five glioma specimens,collected during the resection surgery in our hospital firom June 2011 to June 2014,were used in our experiment;among them,55 were low-grade gliomas and 40 were high-grade gliomas.Immunohistochemistry and real time-PCR were used to assay the protein and mRNA expressions of HMGB1 and TLR4 in glioma tissues and peritumoral tissues,and the relation between HMGB1/TLR4 and glioma-associated epilepsy was analyzed.Results The incidence of glioma-associated epilepsy was 35.79% (34/95),and the incidence of glioma-associated epilepsy in low-grade gliomas (49.09%) was significantly higher than that in high-grade gliomas (17.50%)(x2=10.057,P=0.002).Immunohistochemisty and RT-PCR showed that the protein and mRNA expressions of HMGB1/TLR4 in the peritumoral tissues with glioma-associated epilepsy were significantly higher than those in the peritumoral tissues without glioma-associated epilepsy (P〈0.05),while no significant difference was noted between glioma tissues with and without epilepsy (P〉0.05).Conclusion Over-expression of HMGB1 and TLR4 in peritumoral tissues of glioma patients may be related with the development of glioma-associated epilepsy,which may be a new target in glioma therapy.
出处
《中华神经医学杂志》
CAS
CSCD
北大核心
2015年第6期563-566,共4页
Chinese Journal of Neuromedicine
基金
河南省教育厅科学技术研究重点项目(14A320078)